Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.0K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.1K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.9K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.5K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry.

Internal medicine journal·2026
Same author

A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Analysing allergen-environment interactions to identify drivers of asthma presentations in Metropolitan Melbourne, 2017-2022.

Scientific reports·2026
Same author

Climate change and allergic diseases: A scoping review.

The journal of climate change and health·2026
Same author

From Proteome to miRNome: A Review of Multi-Omics Ocular Allergy Research Using Human Tears.

International journal of molecular sciences·2026
Same author

Exploring Evidence-Based Approaches to Ocular Allergy Among Australian Health Practitioners.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Dec 1, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.2K

Epidemic Thunderstorm Asthma: Lessons Learned from the Storm Down-Under.

Dwan Price1, Kira M Hughes2, Francis Thien3

  • 1NeuroAllergy Research Laboratory (NARL), School of Life and Environmental Sciences, Faculty of Science, Engineering and Built Environment, Deakin University, Waurn Ponds, VIC, Australia; NeuroAllergy Research Laboratory (NARL), School of Life and Environmental Sciences, Faculty of Science, Engineering and Built Environment, Deakin University, Burwood, VIC, Australia; Deakin AIRwatch Pollen and Spore Counting and Forecasting Facility, Deakin University, Burwood and Waurn Ponds, VIC, Australia.

The Journal of Allergy and Clinical Immunology. in Practice
|November 11, 2020
PubMed
Summary

Epidemic thunderstorm asthma (ETSA) is a growing global threat, exacerbated by climate change. Identifying at-risk individuals through biomarkers is crucial for preventing fatalities and healthcare system overload.

Keywords:
Allergen-specific IgEAllergensAllergic rhinitisAsthma treatmentBiomarkersEpidemic thunderstorm asthmaGrass pollenMelbourneRisk factorsSensitization

More Related Videos

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.1K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.9K

Related Experiment Videos

Last Updated: Dec 1, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.2K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.1K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.9K

Area of Science:

  • Environmental health
  • Epidemiology
  • Clinical medicine

Background:

  • Epidemic thunderstorm asthma (ETSA) poses a significant global health risk with potentially catastrophic outcomes.
  • Climate change is increasing the frequency, severity, and unpredictability of ETSA events.
  • Current understanding of ETSA's clinical mechanisms and at-risk populations requires updating.

Purpose of the Study:

  • To review the clinical mechanisms of ETSA.
  • To summarize the global prevalence and characteristics of individuals at moderate to severe risk of ETSA.
  • To identify key patient characteristics for personalized treatment and risk mitigation.

Main Methods:

  • Literature review of clinical studies and epidemiological data on ETSA.
  • Analysis of patient characteristics associated with severe ETSA outcomes.
  • Synthesis of current knowledge on ETSA pathophysiology and risk factors.

Main Results:

  • ETSA events are unpredictable and can overwhelm healthcare systems.
  • Climate change is a significant driver of increasing ETSA risk.
  • Specific patient biomarkers and clinical characteristics are associated with higher ETSA risk.

Conclusions:

  • Identifying at-risk individuals through their characteristics and potential biomarkers is a key prophylactic strategy.
  • Personalized treatment plans based on identified risk factors can help prevent loss of life.
  • Further research into ETSA mechanisms and risk stratification is essential for public health preparedness.